tbuckley/cabot-search huggingface dataset:
Cells of the Osteoblast Lineage Confer Myeloma Cell Resistance to Established and Investigational Therapeutic Agents
Authors: Catriona A. Hayes, Paul Dowling, Richard W.J. Groen, Douglas W. McMillin, Jake E. Delmore, Hannah M. Jacobs, Niels W.C.J. van de Donk, Eugen Dhimolea, Paul G. Richardson, Kenneth C. Anderson, Martin Clynes, Peter O'Gorman, Constantine S. Mitsiades
Journal: Blood (2012)
miR-16 and miR-125b are involved in barrier function dysregulation through the modulation of claudin-2 and cingulin expression in the jejunum in IBS with diarrhoea
Authors: Cristina Martínez, Bruno K Rodiño-Janeiro, Beatriz Lobo, Megan L Stanifer, Bernd Klaus, Martin Granzow, Ana M González-Castro, Eloisa Salvo-Romero, Carmen Alonso-Cotoner, Marc Pigrau, Ralph Roeth, Gudrun Rappold, Wolfgang Huber, Rosa González-Silos, Justo Lorenzo, Inés de Torres, Fernando Azpiroz, Steeve Boulant, María Vicario, Beate Niesler, Javier Santos
Journal: Gut (2017)

<h3>Objective</h3> Micro-RNAs (miRNAs) play a crucial role in controlling intestinal epithelial barrier function partly by modulating the expression of tight junction (TJ) proteins. We have previously shown differential messenger RNA (mRNA) expression correlated with ultrastructural abnormalities of the epithelial barrier in patients with diarrhoea-predominant IBS (IBS-D). However, the participation of miRNAs in these differential mRNA-associated findings remains to be established. Our aims were (1) to identify miRNAs differentially expressed in the small bowel mucosa of patients with IBS-D and (2) to explore putative target genes specifically involved in epithelial barrier function that are controlled by specific dysregulated IBS-D miRNAs. <h3>Design</h3> Healthy controls and patients meeting Rome III IBS-D criteria were studied. Intestinal tissue samples were analysed to identify potential candidates by: (a) miRNA-mRNA profiling; (b) miRNA-mRNA pairing analysis to assess the co-expression profile of miRNA-mRNA pairs; (c) pathway analysis and upstream regulator identification; (d) miRNA and target mRNA validation. Candidate miRNA-mRNA pairs were functionally assessed in intestinal epithelial cells. <h3>Results</h3> IBS-D samples showed distinct miRNA and mRNA profiles compared with healthy controls. TJ signalling was associated with the IBS-D transcriptional profile. Further validation of selected genes showed consistent upregulation in 75% of genes involved in epithelial barrier function. Bioinformatic analysis of putative miRNA binding sites identified hsa-miR-125b-5p and hsa-miR-16 as regulating expression of the TJ genes <i>CGN</i> (cingulin) and <i>CLDN2</i> (claudin-2), respectively. Consistently, protein expression of CGN and CLDN2 was upregulated in IBS-D, while the respective targeting miRNAs were downregulated. In addition, bowel dysfunction, perceived stress and depression and number of mast cells correlated with the expression of hsa-miR-125b-5p and hsa-miR-16 and their respective target proteins. <h3>Conclusions</h3> Modulation of the intestinal epithelial barrier function in IBS-D involves both transcriptional and post-transcriptional mechanisms. These molecular mechanisms include miRNAs as master regulators in controlling the expression of TJ proteins and are associated with major clinical symptoms.
PD0332991, a CDK4/6 Inhibitor, Has An Anti-Leukemic Activity Against Ph+ Leukemia with T315I Mutation in Bcr-Abl; In Vivo Analysis Using Xenograft Mice Model
Authors: Satoshi Saida, Itaru Kato, Takeshi Inukai, Atsushi Nemoto, Kanji Sugita, Yasuhiro Maeda, Akira Niwa, Ken-ichiro Watanabe, Tatsutoshi Nakahata, Toshio Heike
Journal: Blood (2011)
Preliminary Findings from the Prospective Multicenter Surveillance, Epidemiology and Risk Factors for Thrombotic Thrombocytopenic Purpura (SERF-TTP) Study.
Authors: Anaadriana Zakarija, Nicholas Bandarenko, Dilip K. Pandey, Hau Kwaan, Kathryn McCaffrey, Denise Finley, Ken Carson, Paul Yarnold, Charles L. Bennett
Journal: Blood (2004)
Delayed Tumor Seeding Along Axillary Lymph Node Biopsy Tract Visualized on FDG PET/CT
Authors: William Bremer, Yang Lu
Journal: Clinical Nuclear Medicine (2017)

A 59-year-old woman with right breast cancer underwent an ultrasound-guided core needle biopsy of a right axilla lymph node. Pathology results revealed metastases from breast cancer. The patient had serial FDG PET/CT scans for further workup and therapy assessment during the disease course. Hypermetabolic tumor seeding along the needle biopsy tract was not evident at FDG PET/CT scan performed 5 weeks after biopsy but became apparent at 10 weeks after biopsy and progressed subsequently.
Intravaginal immunisation using a novel antigen-releasing ring device elicits robust vaccine antigen-specific systemic and mucosal humoral immune responses
Authors: Paul F. McKay, Jamie F.S. Mann, Aditya Pattani, Vicky Kett, Yoann Aldon, Deborah King, R. Karl Malcolm, Robin J. Shattock
Journal: Journal of Controlled Release (2017)

The generation of effective levels of antigen-specific immunity at the mucosal sites of pathogen entry is a key goal for vaccinologists. We explored topical vaginal application as an approach to initiate local antigen-specific immunity, enhance previously existing systemic immunity or re-target responses to the mucosae. To deliver a protein vaccine formulation to the vaginal mucosal surface, we used a novel vaginal ring device comprising a silicone elastomer body into which three freeze-dried, rod-shaped, hydroxypropylmethylcellulose inserts were incorporated. Each rod contained recombinant HIV-1 CN54gp140 protein (167 μg) ± R848 (167 μg) adjuvant. The inserts were loaded into cavities within each ring such that only the ends of the inserts were initially exposed. Sheep received a prime-boost vaccination regime comprising intramuscular injection of 100 μg CN54gp140 + 200 μg R848 followed by three successive ring applications of one week duration and separated by one month intervals. Other sheep received only the ring devices without intramuscular priming. Serum and vaginal mucosal fluids were sampled every two weeks and analysed by CN54gp140 ELISA and antigen-specific B cells were measured by flow cytometry at necropsy. Vaccine antigen-specific serum antibody responses were detected in both the intramuscularly-primed and vaginal mucosally-primed groups. Those animals that received only vaginal vaccinations had identical IgG but superior IgA responses. Analysis revealed that all animals exhibited mucosal antigen-specific IgG and IgA with the IgA responses 30-fold greater than systemic levels. Importantly, very high numbers of antigen-specific B cells were detected in local genital draining lymph nodes. We have elicited local genital antigen-specific immune responses after topical application of an adjuvanted antigen formulation within a novel vaginal ring vaccine release device. This regimen and delivery method elicited high levels of antigen-specific mucosal IgA and large numbers of local antigen-reactive B cells, both likely essential for effective mucosal protection.
STUDIES ON TYPHUS FEVER
Authors: Hans Zinsser, M. Ruiz Castaneda
Journal: The Journal of Experimental Medicine (1931)

Guinea pigs can be immunized against Mexican typhus virus by peritoneal injections of formalinized Rickettsia material, provided sufficient amounts of the organisms are used. Our results in this respect are analogous to those of Spencer and Parker with carbolized virus of Rocky Mountain spotted fever. The Rickettsia suspensions appear to possess considerable toxicity. We do not wish to be misunderstood as implying that the results in guinea pigs offer anything more than a demonstration of the principle of active immunization with killed Rickettsiae. Application to man will have to be worked out, and preliminary to this, we are now attempting to apply the methods to a limited number of monkeys.
AMN107: In Vitro Profile of a New Inhibitor of the Tyrosine Kinase Activity of Bcr-Abl.
Authors: Juergen Mestan, Weisberg Ellen, Cowan-Jacob Sandra, Fabbro Doriano, Furet Pascal, Fendrich Gabriele, Goutte Gerard, Kempf Dominique, Gaugler Markus, Griffin D. James, Manley W. Paul
Journal: Blood (2004)
Superior Efficacy and Selectivity of Novel Small-Molecule Kinase Inhibitors of T790M-Mutant EGFR in Preclinical Models of Lung Cancer
Authors: Jin Kyung Rho, In Yong Lee, Yun Jung Choi, Chang-Min Choi, Jae-Young Hur, Jong Sung Koh, Jaekyoo Lee, Byung-Chul Suh, Ho-Juhn Song, Paresh Salgaonkar, Jungmi Lee, Jaesang Lee, Dong Sik Jung, Sang-Yeob Kim, Dong-Cheol Woo, In-Jeoung Baek, Joo-Yong Lee, Chang Hoon Ha, Young Hoon Sung, Jeong Kon Kim, Woo Sung Kim, Joon Seon Song, Cheol Hyeon Kim, Trever G. Bivona, Jae Cheol Lee
Journal: Cancer Research (2017)

The clinical utility of approved EGFR small-molecule kinase inhibitors is plagued both by toxicity against wild-type EGFR and by metastatic progression in the central nervous system, a disease sanctuary site. Here, we report the discovery and preclinical efficacy of GNS-1486 and GNS-1481, two novel small-molecule EGFR kinase inhibitors that are selective for T790M-mutant isoforms of EGFR. Both agents were effective in multiple mouse xenograft models of human lung adenocarcinoma (T790M-positive or -negative), exhibiting less activity against wild-type EGFR than existing approved EGFR kinase inhibitors (including osimertinib). In addition, GNS-1486 showed superior potency against intracranial metastasis of EGFR-mutant lung adenocarcinoma. Our results offer a preclinical proof of concept for new EGFR kinase inhibitors with the potential to improve therapeutic index and efficacy against brain metastases in patients. Cancer Res; 77(5); 1200-11. ©2017 AACR.
Elotuzumab In Combination with Lenalidomide and Low-Dose Dexamethasone In Patients with Relapsed/Refractory Multiple Myeloma: Interim Results of a Phase 1 Study
Authors: Sagar Lonial, Ravi Vij, Jean-Luc Harousseau, Thierry Facon, Philippe Moreau, Xavier Leleu, Amitabha Mazumder, Jonathan L Kaufman, Christopher E Westland, Claire Tsao, Anil K Singhal, Sundar Jagannath
Journal: Blood (2010)
What Numbers Don't Say: Immunogenetic Evidence Shows That High-Count MBL Resembles Rai 0 CLL While Low-Count MBL Does Not.
Authors: Anna Vardi, Antonis Dagklis, Lydia Scarfò, Diane F. Jelinek, Darren J Newton, Chi Doughty, Julia Almeida, Arancha Rodriguez-Caballero, Sallie D. Allgood, Mark C. Lanasa, Agostino Cortelezzi, Ester M Orlandi, Silvio Veronese, Marco Montillo, Andy Rawstron, Tait D. Shanafelt, Alberto Orfao, Kostas Stamatopoulos, Paolo Ghia
Journal: Blood (2012)
Pediatric-Type Nodal Follicular Lymphoma in Children and Adults Is Nearly Genetically Silent and Biologically Distinct from Typical Follicular Lymphoma
Authors: Abner Louissaint, Kristian T. Schafernak, Julia T. Geyer, Alexandra E. Kovach, Dita Gratzinger, Christine G. Roth, Christian N. Paxton, Sunhee Kim, Chungdak Namgyal, Elizabeth A. Morgan, Sarah T. South, Marian H. Harris, Ephraim P. Hochberg, Robert P. Hasserjian, Nancy L. Harris, David M. Weinstock
Journal: Blood (2015)
Prognostic Impact of Pretransplant Transfusion Amount on Outcome After Allogeneic Stem Cell Transplantation In Adult Patients with Severe Aplastic Anemia
Authors: Sung-Eun Lee, Jong-Wook Lee, Seung-Ah Yahng, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Heeje Kim, Chang-Ki Min, Seok Lee, Seok-Goo Cho, Dong-Wook Kim, Woo-Sung Min, Chong-Won Park
Journal: Blood (2010)
Transformed Lymphoma: Incidence and Long-Term Outcome.
Authors: Abdulwahab J. Al-Tourah, Mukesh Chhanabhai, Paul J. Hoskins, Richard J. Klasa, Kerry J. Savage, Laruie H. Sehn, Tamara N. Shenkier, Randy D. Gascoyne, Joseph M. Connors
Journal: Blood (2004)
Comprehensive Molecular Profiling of T-Cell Acute Lymphoblastic Leukemia Identifies Mutations in 76 (97.4%) of 78 Patients
Authors: Vera Grossmann, Alexander Kohlmann, Sandra Weissmann, Susanne Schnittger, Valentina Artusi, Sonja Schindela, Kathrin Stadler, Torsten Haferlach, Wolfgang Kern, Claudia Haferlach
Journal: Blood (2011)
Pegylated Interferon-ALFA-2A (PEG-IFN-α-2A; PEGASYS) Therapy Renders High Clinical and Molecular Response Rates in Patients with Essential Thrombocythemia (ET) and Polycythemia VERA (PV)
Authors: Alfonso Quintas-Cardama, Hagop M. Kantarjian, Guillermo Garcia-Manero, Jorge Cortes, Marie Ann Richie, Gautam Borthakur, Srdan Verstovsek
Journal: Blood (2008)
Maintenance Treatment after Autologous Peripheral Blood Stem Cell Transplantation (PBSCT) in Multiple Myeloma (MM) with a Unique Weekly Dose of Pegylated Interpheron alpha2b (Pegintron®): Preliminary Clinical Results in 30 Patients of a Phase II Multicentric Study.
Authors: Adrian Alegre, B. Aguado, J. Garcia-Laraña, J.J. Lahuerta, M.V. Mateos, R. Rodriguez-Notario, B. Navas, J.M. Fernandez-Rañada, J.F. San Miguel
Journal: Blood (2007)
Thrombopoietin Can Induce Tolerogenic Responses Via the Modulation of Thymic and Splenic T Lymphocyte Populations in a Murine Model of Immune Thrombocytopenia (ITP)
Authors: John W. Semple, Xu Zhang, Yu Hu, Li Guo, Edwin R. Speck, Heyu Ni, Rukhsana Aslam
Journal: Blood (2012)
A Phase II, Randomized, Multi-Centre, Open-Label, Active-Controlled, Dose-Finding Trial of F-627 (benefilgrastim) in Women with Breast Cancer Receiving Myelotoxic Chemotherapy
Authors: John Glaspy, Tom Tang, Dean Rutty, Xiaoqiang Yan, Igor Bondarenko, Dmitrii Krasnozhon
Journal: Blood (2014)
Nilotinib Efficacy According to Baseline BCR-ABL Mutations in Patients with Imatinib-Resistant Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
Authors: Andreas Hochhaus, Dong-Wook Kim, Giovanni Martinelli, Timothy P. Hughes, Simona Soverini, Susan Branford, Martin C Müller, Philipp Erben, Ariful Haque, Yaping Shou, Giuseppe Saglio, Jerald P. Radich
Journal: Blood (2008)
Identification of the Novel Erythroid-Specific Enhancer in the First Intron of Human ALAS2 Gene; Tthe Mutation Disrupting GATA Transcription Factor-Binding Site in the Enhancer Causes X-Linked Sideroblastic Anemia
Authors: Kazumichi Furuyama, Kiriko Kaneko, Tohru Fujiwara, Hideo Harigae, Shigeki Shibahara
Journal: Blood (2012)
Why do we remember? The communicative function of episodic memory
Authors: Johannes B. Mahr, Gergely Csibra
Journal: Behavioral and Brain Sciences (2017)

Episodic memory has been analyzed in a number of different ways in both philosophy and psychology, and most controversy has centered on its self-referential, 'autonoetic' character. Here, we offer a comprehensive characterization of episodic memory in representational terms, and propose a novel functional account on this basis. We argue that episodic memory should be understood as a distinctive epistemic attitude taken towards an event simulation. On this view, episodic memory has a metarepresentational format and should not be equated with beliefs about the past. Instead, empirical findings suggest that the contents of human episodic memory are often constructed in the service of the explicit justification of such beliefs. Existing accounts of episodic memory function that have focused on explaining its constructive character through its role in 'future-oriented mental time travel' neither do justice to its capacity to ground veridical beliefs about the past nor to its representational format. We provide an account of the metarepresentational structure of episodic memory in terms of its role in communicative interaction. The generative nature of recollection allows us to represent and communicate the reasons for why we hold certain beliefs about the past. In this process, autonoesis corresponds to the capacity to determine when and how to assert epistemic authority in making claims about the past. A domain where such claims are indispensable are human social engagements. Such engagements commonly require the justification of entitlements and obligations, which is often possible only by explicit reference to specific past events.
Influence of Inflammatory Factors Produced during Graft-Versus-Host Disease on Immunological Properties of Mesenchymal Stem Cells (MSC).
Authors: Karin Tarte, Delphine Monnier, Olivier Tribut, Joelle Dulong, Céline Bonnaventure, Patricia Ame-Thomas, Nadège Bescher, Thierry Fest, Thierry Lamy, Gilbert Semana
Journal: Blood (2006)
Donor Single Nucleotide Polymorphism in the CCR9 Gene Affects the Incidence of Acute Skin Graft-Versus-Host Disease
Authors: Yoshihiro Inamoto, Makoto Murata, Yachiyo Kuwatsuka, Akane Tsujimura, Kyoko Sugimoto, Taku Oba, Makoto Onizuka, Seitaro Terakura, Akira Katsumi, Koichi Miyamura, Yoshihisa Kodera, Tomoki Naoe
Journal: Blood (2008)
Retraction of “Tunable Plasmonic Nanoprobes for Theranostics of Prostate Cancer”
Authors: Ekaterina Y. Lukianova-Hleb, Alexander O. Oginsky, Adam P. Samaniego, Derek L. Shenefelt, Daniel S. Wagner, Jason H. Hafner, Mary C. Farach-Carson, Dmitri O. Lapotko
Journal: Theranostics (2017)

[This retracts the article on p. 3 in vol. 1, PMID: 21547151.].
Biocompatible Multifunctional Black‐Silicon for Implantable Intraocular Sensor
Authors: Jeong Oen Lee, Vinayak Narasimhan, Juan Du, Blaise Ndjamen, David Sretavan, Hyuck Choo
Journal: Advanced Healthcare Materials (2017)

Multifunctional black-silicon (b-Si) integrated on the surface of an implantable intraocular pressure sensor significantly improves sensor performance and reliability in six-month in vivo studies. The antireflective properties of b-Si triples the signal-to-noise ratio and increases the optical readout distance to a clinically viable 12 cm. Tissue growth and inflammation response on the sensor is suppressed demonstrating desirable anti-biofouling properties. As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Prognostic Factors for Survival in Invasive Aspergillosis in Adult Oncohematological Patients.
Authors: Yasmine Nivoix, Michel Velten, Valérie Letscher-Bru, Alireza Moghaddam, Cécile Fohrer, Bruno Lioure, Karin Bilger, Shanti Natarajan-Amé, Philippe Lutun, Luc Marcellin, Jean-Pierre Bergerat, Raoul Herbrecht
Journal: Blood (2006)
Leukemic T-PLL Cells Exhibit Short and Narrowly Distributed Telomere Lengths and High Telomerase Activities, Associated with Rapid and Dose-Dependent Cell Death Following Telomerase Inhibition by Imetelstat Sodium.
Authors: Gabriela M. Baerlocher, Katia Bassett, Dirk de Beer, Laurence Elias, Ning F Go, Alexander Roeth
Journal: Blood (2009)
RAD001: A Clinico-Biological Phase I GOELAMS trial of Everolimus Association with High Dose Chemotherapy in Late Relapsing AML Patients Under 65 Years of Age
Authors: Sophie Park, Nicolas Chapuis, Franck Saint Marcoux, Christian Recher, Norbert Vey, Thomas Prebet, Patrice Chevallier, Jean-Yves Cahn, Arnaud Pigneux, Bruno Lioure, Francis Witz, Thierry Lamy, Annabelle Merlat, Roselyne Delepine, Francois Dreyfus, Marie-christine Béné, Norbert Ifrah, Didier Bouscary
Journal: Blood (2011)
Brief Report: Synovial Fluid White Blood Cell Count in Knee Osteoarthritis: Association With Structural Findings and Treatment Response
Authors: Paul S. McCabe, Matthew J. Parkes, Nasimah Maricar, Charles E. Hutchinson, Anthony Freemont, Terence W. O'Neill, David T. Felson
Journal: Arthritis & Rheumatology (2016)

Objective Osteoarthritis (OA) is a disease with a significant inflammatory component. The aim of this analysis was to determine the relationship between synovial fluid (SF) white blood cell (WBC) count and 2 parameters: disease severity and the reduction in knee pain after intraarticular (IA) steroid injection. Methods Subjects with painful knee OA were recruited for participation in an open‐label study of IA steroid therapy. Information was obtained about knee pain using the Knee Injury and Osteoarthritis Outcome Score (KOOS) questionnaire, and a proportion of subjects underwent magnetic resonance imaging (MRI). Prior to injection with 80 mg methylprednisolone acetate, the index knee joint was aspirated and the fluid obtained was forwarded for assessment of SF WBC count. Results Information on SF WBC count was available for 55 subjects. An increase in WBC count category (≤100, 101–250, and 251–1,000 cells/mm 3 ) was associated with an increase in synovial tissue volume ( P = 0.028) and with other MRI‐based measures of disease severity. Also, with each increase in SF WBC count category, there was a greater reduction in KOOS score after steroid injection (for WBC count of ≤100 cells/mm 3 [referent], mean ± SD 12.5 ± 15.2; for WBC count of 101–250 cells/mm 3 , mean ± SD 21.3 ± 20.6 [β coefficient 0.279, P = 0.049]; for WBC count of 251–1,000 cells/mm 3 , mean ± SD 29.3 ± 15.2 [β coefficient 0.320, P = 0.024]). Conclusion Although all participants in the analysis had SF WBC counts within the “normal” range, total SF WBC count appears to be a biomarker for synovitis on MRI and may also predict response to antiinflammatory treatment.
Elastance bronchodilator response reflects asthma pathology
Authors: Swati Bhatawadekar, Del Leary, Scott Fulton, Paul Hernandez, Colm McParland, Geoff Maksym
Journal: European Respiratory Journal (2013)

Introduction: Respiratory system resistance Rrs measured by the forced oscillation technique (FOT) and FEV1 measure airflow obstruction but are dominated by central airways. Respiratory system elastance Ers is thought to reflect the available compliant airspaces and increases with ventilation heterogeneity, and thus could be a good measure of peripheral airway closure, or opening in reversibility testing. We investigated the hypothesis that changes in Ers with bronchodilator (BD) are better able to assess peripheral airway disease in asthma. Materials &Methods: FOT was measured at 4-22Hz in 19 asthmatics and 18 controls pre and post BD (Salbutamol 200 mcg). We developed an anatomically based 26 generation airway tree model (Leary D et al., J Appl Physiol. 2012 112:167-75) and evaluated effects of heterogeneous peripheral airway closure and global airway narrowing for comparison to the in vivo data. Results: In asthma, Rrs and Ers showed a larger BD response (25%) than FEV1 (16%) and, while Rrs decreased in both groups (25%, 12%), only Ers decreased in asthma (p
ENGAGE- 501: Phase 2 Study Investigating the Role of Epigenetic Therapy with Entinostat (SNDX-275) In Relapsed and Refractory Hodgkin's Lymphoma (HL), Interim Results
Authors: Anas Younes, Francisco Hernandez, R. Gregory Bociek, Yvette L. Kasamon, Peter Lee, Lia Gore, Daniela Buglio, Amanda Copeland
Journal: Blood (2010)
Structure-Guided Design of A Novel High Affinity Integrin αIIbβ3 Receptor Antagonist (RUC-2) That Displaces Mg2+ From the β3 MIDAS,
Authors: Jieqing Zhu, Won-Seok Choi, Joshua G. McCoy, Ana Negri, Jianghai Zhu, Sarasija Naini, Jihong Li, Min Shen, Wenwei Huang, Craig J. Thomas, Marta Filizola, Timothy Springer, Barry S. Coller
Journal: Blood (2011)
Dose Escalation of Azacitidine in Patients Failing Standard or Investigational Combinations of the Agent in the Myelodysplastiic Syndrome or Evolved AML
Authors: Lewis R. Silverman, Shyamala C. Navada, Rosalie Odchimar-Reissig, Maria Michalak, Erin P Demakos, James F Holland
Journal: Blood (2012)
Regulatory T Lymphocytes and Tumor-Associated Macrophages Have No Impact On Treatment Response and Survival in Brazilian Patients with Classical Hodgkin Lymphoma
Authors: Mariane Cristina Gennari Assis, Antonio H. F. M. Campos, José Salvador Rodrigues de Oliveira, Fernando A Soares, Joyce M. K. Silva, Priscilla B Silva, Adriana M. Damasco Penna, Eni Maria Souza, Otávio Cesar Carvalho Guimarães Baiocchi
Journal: Blood (2012)
Phase II Study of Proteasome Inhibitor Bortezomib (Velcade®) in Patients with Relapsed/Refractory T-Cell Lymphoma: Preliminary Results.
Authors: Pier Luigi Zinzani, Monica Tani, Gerardo Musuraca, Vittorio Stefoni, Enrica Marchi, Mariapaola Fina, Michele Baccarani
Journal: Blood (2006)